- NCT00237302
- Primary Citation Not Available
- Data Specification Not Available
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNervous System DiseasesEnrollment162% Female48.4%% White77.1%
Product ClassAnticonvulsantsSponsor Protocol NumberCAPSS-122Data PartnerJohnson & JohnsonCondition StudiedMigraine DisordersMean/Median Age (Years)11.1
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Clinical Study Report Available